Trinity Biotech plc acquires EpiCapture Limited to expand into oncology diagnostics
Acquiring Company
Trinity Biotech
Acquired Company
EpiCapture Limited
BrayDublinManufacturingBiotechnologyHealth CareBiotechnologyHealth CareMedicalDescription
Trinity Biotech plc, specializing in human diagnostics and diabetes management, has acquired EpiCapture Limited, a firm specializing in non-invasive tests for aggressive prostate cancer risk assessment. This strategic acquisition marks Trinity Biotech's entry into the oncology diagnostics market and reflects its commitment to improving patient outcomes through innovative diagnostic technologies.
Quick answer
Trinity Biotech is acquiring EpiCapture Limited, announced October 25, 2024. Trinity Biotech is based in Bray, Wicklow, Ireland.
- How much did Trinity Biotech pay for EpiCapture Limited?
- The deal value was not disclosed.
- What does Trinity Biotech do?
- Trinity Biotech plc is a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors.
- Where are Trinity Biotech and EpiCapture Limited based?
- Trinity Biotech is based in Bray, Wicklow, Ireland. EpiCapture Limited is based in Dublin, Dublin, Ireland.
- Who are the decision-makers at Trinity Biotech?
- Fundz holds 5 contacts at Trinity Biotech. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- H.B. Fuller Company signs agreements to acquire Medifill Ltd. and GEM S.r.l. to expand its Medical Adhesive Technologies business (December 2, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
- Flat Medical strengthens market leadership with acquisition of InjeQ assets, including FDA-Designated Breakthrough Device IQ-Tip® (September 25, 2024)
- Vitalograph acquires Morgan Scientific to strengthen US commercial footprint (September 23, 2024)
- Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne (November 25, 2024)
Who to call at Trinity Biotech, and when
When Trinity Biotech changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Trinity Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Trinity Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Trinity Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Trinity Biotech makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired EpiCapture Limited?
EpiCapture Limited was acquired by Trinity Biotech, based in Bray. The deal was reported on October 25, 2024. Trinity Biotech plc is a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors. Trinity Biotech is publicly traded (TRIB) and operates in Manufacturing.
When did Trinity Biotech acquire EpiCapture Limited?
Trinity Biotech's acquisition of EpiCapture Limited was reported on October 25, 2024. Trinity Biotech plc, specializing in human diagnostics and diabetes management, has acquired EpiCapture Limited, a firm specializing in non-invasive tests for aggressive prostate cancer risk assessment. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does EpiCapture Limited do?
EpiCapture's mission is to improve the care of cancer patients through the development of accurate, non-invasive, urine tests to identify aggressive cancers. EpiCapture-prostate is the company's first product to progress to commercialisation. It is privately held, operating in Biotechnology, and is based in Dublin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.